Types of Insulin Pumps

There are several ways to categorise insulin pumps. Two important axes are tubed vs. tubeless (patch) and standard vs. automated/closed-loop systems. Below are the main types.

1. Traditional Tubed Pumps

These are the classic insulin pumps: a reservoir in the device → tubing → infusion set (cannula) in the skin. (PMC)
Pros:

  • Precise control of both basal (background) and bolus (meal/ correction) insulin dosing. (Dr Joaquim Proenca Clinic)
  • A broad range of infusion‐set options (lengths, site locations) since tubing gives flexibility. (adces.org)
  • Good for people who require varying basal rates, different day/night patterns, or many hours of infusion. (PMC)
    Cons:
  • Tubing can be inconvenient: may catch on things, restrict movement, get kinked or accidentally disconnected. (London Diabetes Centre)
  • More visible/bulky than tubeless options; some people may find wearing it less discreet.
  • Requires changing infusion sets, managing tubing, potentially more “hardware” to deal with.
  • Risk of infusion/ delivery failures (kinks, blockages, disconnection) which can lead to poor insulin delivery. (Cleveland Clinic)

2. Tubeless / “Patch” Pumps

These pumps eliminate (or greatly reduce) tubing: the insulin reservoir + cannula sit in a pod attached directly to the skin, and you control the system wirelessly/remote. (Cleveland Clinic)
Pros:

  • More freedom of movement; less tubing means less snagging/less visible hardware. (adces.org)
  • Likely more discreet and potentially more accepted by active users, sportspeople, or those who dislike tubing.
  • Some may be waterproof or more compact. (Cleveland Clinic)
    Cons:
  • Usually smaller insulin reservoir (because pod size must be compact) → may mean more frequent changes or less flexibility for high insulin doses. (Dr Joaquim Proenca Clinic)
  • Skin adhesion matters: some users have skin irritation, adhesive problems. (Mount Sinai Health System)
  • Pod stays on the body; if it fails or detaches, you might lose basal delivery until replaced.
  • Fewer tubing options may limit site placement flexibility in some cases.

3. Automated / Hybrid Closed-Loop Insulin Pumps

These are advanced systems where the pump communicates with a continuous glucose monitor (CGM) and uses algorithms to adjust insulin delivery (basal/bolus) to some extent automatically. (adces.org)
Pros:

  • Often better glycaemic control (e.g., more time in target, fewer high/low excursions). (PMC)
  • Reduced burden: less manual adjusting, fewer decisions especially for basal rates.
  • Good for people who struggle with hypoglycaemia, have unpredictable schedules, or want more “hands-off” support.
    Cons:
  • More complex to set up and learn: the algorithms, CGM integration, calibration, settings require more training. (PMC)
  • Higher cost, both device and supplies. (London Diabetes Centre)
  • Dependence on sensor accuracy, algorithm reliability, more moving parts (so more potential points of failure).
  • Some systems may limit flexibility (you’re somewhat depending on what the algorithm approves) and you still must do carbohydrate counting etc.

General Advantages & Disadvantages of Insulin Pumps

Regardless of type, here’s a summary of what pumps as a category bring — good and less good.

Advantages:

  • More precise dosing: Pump therapy allows fractional insulin dosing, fine-tuning of basal rates, etc. (Mount Sinai Health System)
  • Better glucose control (in many studies) vs. multiple daily injections (MDI) in certain populations. (PMC)
  • Improved flexibility: Easier to adjust for meals, exercise, variable schedule. (London Diabetes Centre)
  • Fewer injections (once set up, you don’t need to inject basal insulin multiple times). (Cleveland Clinic)
  • Some improved quality of life (for people who find MDI burdensome). (London Diabetes Centre)

Disadvantages:

  • Cost: Pumps and supplies are more expensive than many injection regimens. (London Diabetes Centre)
  • Technical/device-dependence: If something fails (infusion set kinked, pump malfunctions), risk of insulin delivery interruption → high blood sugar, ketoacidosis. (Cleveland Clinic)
  • Being “attached”: Having a device on your body constantly (or nearly) may be inconvenient, uncomfortable or a psychological burden. (Mount Sinai Health System)
  • Learning curve: Using the pump effectively requires training, carbohydrate counting, setting basal/bolus parameters, monitoring. (Mount Sinai Health System)
  • Site/adhesive issues: Skin reactions, infusion site problems (infections, inflammation) can happen. (Mount Sinai Health System)

Which Type Might Suit Whom?

Here are some considerations based on lifestyle and clinical needs:

  • If you have a high insulin requirement, or complicated basal/bolus needs (e.g., variable day/night, lots of activity), a traditional tubed pump might offer the flexibility.
  • If you are active, dislike tubing, prefer a less visible device, or want fewer external parts, a patch/tubeless pump could appeal.
  • If you are comfortable with technology, want to minimise the effort of adjusting insulin and use a CGM, then a closed‐loop/automated pump may offer advantages.
  • If your diabetes is well controlled on injections and you’re happy with the routine, pump may not offer big enough benefit to justify cost/complexity. (Diabetes Deutschland)

10 major insulin pump (insulin-delivery device) companies worldwide Nov 2025

10 major insulin pump (insulin-delivery device) companies worldwide, with their region, key model(s), and home page links. This should help you see what’s available globally and compare. (Note: availability, regulatory approvals and models vary by country.)

#

Company

Region / Headquarters

Key Models & Features

Website

1

Insulet Corporation

USA (Massachusetts)

“Omnipod” tubeless/patch pump; wearable pod with no tubing. (Insulet)

https://www.insulet.com/

2

Tandem Diabetes Care, Inc.

USA (California)

“t:slim X2”, with Control-IQ/automated algorithm, CGM integration. (Tandem Diabetes)

https://www.tandemdiabetes.com/

3

Medtronic plc

Global / Ireland-based HQ

“MiniMed” series; strong in closed-loop and pump+CGM systems. (Fortune Business Insights)

https://www.medtronic.com/

4

F. Hoffmann‑La Roche Ltd

Switzerland

Under Roche Diabetes Care: pump systems + glucose monitoring + digital apps. (Claight)

https://www.roche.com/ (navigate to Diabetes Care)

5

Ypsomed AG

Switzerland

mylife YpsoPump and related infusion/diabetes systems. (Wikipedia)

https://www.ypsomed.com/

6

SOOIL Development Co., Ltd.

South Korea

DANA series pumps; cost-effective solutions for global markets. (Fortune Business Insights)

https://www.sooil.com/eng/

7

ViCentra B.V.

Netherlands

“Kaleido” pump system (Europe focused) among newer entrants. (Fortune Business Insights)

https://hellokaleido.com/

8

EOFlow Co., Ltd.

South Korea

Wearable insulin patch/pump systems (emerging market player) reported in market reports. (Fortune Business Insights)

(Search “EOFlow insulin pump” for website)

9

CeQur Simplicity

Switzerland (brand)

Patch-type insulin delivery systems; smaller scale but growing. (Fortune Business Insights)

(Search “CeQur insulin pump” for website)

10

MannKind Corporation

USA

Though better known for insulin inhalation, also listed among pump-market players in industry reports. (GlobeNewswire)

https://www.mannkindcorp.com/

Notes / caveats:

  • Regulatory approvals differ by country: a pump available in the USA may not yet be approved in Europe or India, or the model may vary.
  • “Region” above is where the company is headquartered; many serve multiple markets (USA, Europe, Asia).
  • Newer/emerging players (patch pumps, wearable pods) may have less market share but are important to watch.
  • For India: While not many domestic full-pump manufacturers are globally known yet, many of the above companies distribute in India, or partner locally.
  • Always check local availability, reimbursement and support/consumables in your country (Germany/EU in your case) before choosing a pump.